COVID-19 Impact on Global Parenteral Drugs Market Insights, Forecast to 2026
Parenteral Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Parenteral Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Parenteral Drugs market is segmented into
The Parenteral Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Parenteral Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Parenteral Drugs Market Share Analysis
Parenteral Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Parenteral Drugs business, the date to enter into the Parenteral Drugs market, Parenteral Drugs product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Parenteral Drugs market is segmented into
- LVP Drug
- SVP Drug
- Hospitals
- Medical Centers
- Others
The Parenteral Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Parenteral Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Parenteral Drugs Market Share Analysis
Parenteral Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Parenteral Drugs business, the date to enter into the Parenteral Drugs market, Parenteral Drugs product introduction, recent developments, etc.
The major vendors covered:
- Ostuka Pharmaceutical
- Teva Pharmaceutical Industries
- Kelun Pharma
- Cook Pharmica
- Patheon
- BAG Healthcare
- Beximco Pharma
- Baxter Healthcare Corporation
- B. Braun
- Fresenius
- Albert David
- BML Parenteral Drugs
- Pfizer (Hospira)
- Pisa
- Ozon Pharmaceuticals Ltd
- Aspen Holdings
- PSI Ltd
- Wintac Limited
- AXA Parenterals Ltd
- Acebright
- Southwest Pharmaceutical
- Abbott
1 STUDY COVERAGE
1.1 Parenteral Drugs Product Introduction
1.2 Market Segments
1.3 Key Parenteral Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Parenteral Drugs Market Size Growth Rate by Type
1.4.2 LVP Drug
1.4.3 SVP Drug
1.5 Market by Application
1.5.1 Global Parenteral Drugs Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Medical Centers
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Parenteral Drugs Industry Impact
1.6.1 How the Covid-19 is Affecting the Parenteral Drugs Industry
1.6.1.1 Parenteral Drugs Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Parenteral Drugs Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Parenteral Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Parenteral Drugs Market Size Estimates and Forecasts
2.1.1 Global Parenteral Drugs Revenue 2015-2026
2.1.2 Global Parenteral Drugs Sales 2015-2026
2.2 Parenteral Drugs Market Size by Region: 2020 Versus 2026
2.2.1 Global Parenteral Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Parenteral Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL PARENTERAL DRUGS COMPETITOR LANDSCAPE BY PLAYERS
3.1 Parenteral Drugs Sales by Manufacturers
3.1.1 Parenteral Drugs Sales by Manufacturers (2015-2020)
3.1.2 Parenteral Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Parenteral Drugs Revenue by Manufacturers
3.2.1 Parenteral Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Parenteral Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Parenteral Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Parenteral Drugs Revenue in 2019
3.2.5 Global Parenteral Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Parenteral Drugs Price by Manufacturers
3.4 Parenteral Drugs Manufacturing Base Distribution, Product Types
3.4.1 Parenteral Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Parenteral Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Parenteral Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Parenteral Drugs Market Size by Type (2015-2020)
4.1.1 Global Parenteral Drugs Sales by Type (2015-2020)
4.1.2 Global Parenteral Drugs Revenue by Type (2015-2020)
4.1.3 Parenteral Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Parenteral Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Parenteral Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Parenteral Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Parenteral Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Parenteral Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Parenteral Drugs Market Size by Application (2015-2020)
5.1.1 Global Parenteral Drugs Sales by Application (2015-2020)
5.1.2 Global Parenteral Drugs Revenue by Application (2015-2020)
5.1.3 Parenteral Drugs Price by Application (2015-2020)
5.2 Parenteral Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Parenteral Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Parenteral Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Parenteral Drugs Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Parenteral Drugs by Country
6.1.1 North America Parenteral Drugs Sales by Country
6.1.2 North America Parenteral Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Parenteral Drugs Market Facts & Figures by Type
6.3 North America Parenteral Drugs Market Facts & Figures by Application
7 EUROPE
7.1 Europe Parenteral Drugs by Country
7.1.1 Europe Parenteral Drugs Sales by Country
7.1.2 Europe Parenteral Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Parenteral Drugs Market Facts & Figures by Type
7.3 Europe Parenteral Drugs Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Parenteral Drugs by Region
8.1.1 Asia Pacific Parenteral Drugs Sales by Region
8.1.2 Asia Pacific Parenteral Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Parenteral Drugs Market Facts & Figures by Type
8.3 Asia Pacific Parenteral Drugs Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Parenteral Drugs by Country
9.1.1 Latin America Parenteral Drugs Sales by Country
9.1.2 Latin America Parenteral Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Parenteral Drugs Market Facts & Figures by Type
9.3 Central & South America Parenteral Drugs Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Parenteral Drugs by Country
10.1.1 Middle East and Africa Parenteral Drugs Sales by Country
10.1.2 Middle East and Africa Parenteral Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Parenteral Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Parenteral Drugs Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Ostuka Pharmaceutical
11.1.1 Ostuka Pharmaceutical Corporation Information
11.1.2 Ostuka Pharmaceutical Description, Business Overview and Total Revenue
11.1.3 Ostuka Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Ostuka Pharmaceutical Parenteral Drugs Products Offered
11.1.5 Ostuka Pharmaceutical Recent Development
11.2 Teva Pharmaceutical Industries
11.2.1 Teva Pharmaceutical Industries Corporation Information
11.2.2 Teva Pharmaceutical Industries Description, Business Overview and Total Revenue
11.2.3 Teva Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Teva Pharmaceutical Industries Parenteral Drugs Products Offered
11.2.5 Teva Pharmaceutical Industries Recent Development
11.3 Kelun Pharma
11.3.1 Kelun Pharma Corporation Information
11.3.2 Kelun Pharma Description, Business Overview and Total Revenue
11.3.3 Kelun Pharma Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Kelun Pharma Parenteral Drugs Products Offered
11.3.5 Kelun Pharma Recent Development
11.4 Cook Pharmica
11.4.1 Cook Pharmica Corporation Information
11.4.2 Cook Pharmica Description, Business Overview and Total Revenue
11.4.3 Cook Pharmica Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Cook Pharmica Parenteral Drugs Products Offered
11.4.5 Cook Pharmica Recent Development
11.5 Patheon
11.5.1 Patheon Corporation Information
11.5.2 Patheon Description, Business Overview and Total Revenue
11.5.3 Patheon Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Patheon Parenteral Drugs Products Offered
11.5.5 Patheon Recent Development
11.6 BAG Healthcare
11.6.1 BAG Healthcare Corporation Information
11.6.2 BAG Healthcare Description, Business Overview and Total Revenue
11.6.3 BAG Healthcare Sales, Revenue and Gross Margin (2015-2020)
11.6.4 BAG Healthcare Parenteral Drugs Products Offered
11.6.5 BAG Healthcare Recent Development
11.7 Beximco Pharma
11.7.1 Beximco Pharma Corporation Information
11.7.2 Beximco Pharma Description, Business Overview and Total Revenue
11.7.3 Beximco Pharma Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Beximco Pharma Parenteral Drugs Products Offered
11.7.5 Beximco Pharma Recent Development
11.8 Baxter Healthcare Corporation
11.8.1 Baxter Healthcare Corporation Corporation Information
11.8.2 Baxter Healthcare Corporation Description, Business Overview and Total Revenue
11.8.3 Baxter Healthcare Corporation Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Baxter Healthcare Corporation Parenteral Drugs Products Offered
11.8.5 Baxter Healthcare Corporation Recent Development
11.9 B. Braun
11.9.1 B. Braun Corporation Information
11.9.2 B. Braun Description, Business Overview and Total Revenue
11.9.3 B. Braun Sales, Revenue and Gross Margin (2015-2020)
11.9.4 B. Braun Parenteral Drugs Products Offered
11.9.5 B. Braun Recent Development
11.10 Fresenius
11.10.1 Fresenius Corporation Information
11.10.2 Fresenius Description, Business Overview and Total Revenue
11.10.3 Fresenius Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Fresenius Parenteral Drugs Products Offered
11.10.5 Fresenius Recent Development
11.1 Ostuka Pharmaceutical
11.1.1 Ostuka Pharmaceutical Corporation Information
11.1.2 Ostuka Pharmaceutical Description, Business Overview and Total Revenue
11.1.3 Ostuka Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Ostuka Pharmaceutical Parenteral Drugs Products Offered
11.1.5 Ostuka Pharmaceutical Recent Development
11.12 BML Parenteral Drugs
11.12.1 BML Parenteral Drugs Corporation Information
11.12.2 BML Parenteral Drugs Description, Business Overview and Total Revenue
11.12.3 BML Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
11.12.4 BML Parenteral Drugs Products Offered
11.12.5 BML Parenteral Drugs Recent Development
11.13 Pfizer (Hospira)
11.13.1 Pfizer (Hospira) Corporation Information
11.13.2 Pfizer (Hospira) Description, Business Overview and Total Revenue
11.13.3 Pfizer (Hospira) Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Pfizer (Hospira) Products Offered
11.13.5 Pfizer (Hospira) Recent Development
11.14 Pisa
11.14.1 Pisa Corporation Information
11.14.2 Pisa Description, Business Overview and Total Revenue
11.14.3 Pisa Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Pisa Products Offered
11.14.5 Pisa Recent Development
11.15 Ozon Pharmaceuticals Ltd
11.15.1 Ozon Pharmaceuticals Ltd Corporation Information
11.15.2 Ozon Pharmaceuticals Ltd Description, Business Overview and Total Revenue
11.15.3 Ozon Pharmaceuticals Ltd Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Ozon Pharmaceuticals Ltd Products Offered
11.15.5 Ozon Pharmaceuticals Ltd Recent Development
11.16 Aspen Holdings
11.16.1 Aspen Holdings Corporation Information
11.16.2 Aspen Holdings Description, Business Overview and Total Revenue
11.16.3 Aspen Holdings Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Aspen Holdings Products Offered
11.16.5 Aspen Holdings Recent Development
11.17 PSI Ltd
11.17.1 PSI Ltd Corporation Information
11.17.2 PSI Ltd Description, Business Overview and Total Revenue
11.17.3 PSI Ltd Sales, Revenue and Gross Margin (2015-2020)
11.17.4 PSI Ltd Products Offered
11.17.5 PSI Ltd Recent Development
11.18 Wintac Limited
11.18.1 Wintac Limited Corporation Information
11.18.2 Wintac Limited Description, Business Overview and Total Revenue
11.18.3 Wintac Limited Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Wintac Limited Products Offered
11.18.5 Wintac Limited Recent Development
11.19 AXA Parenterals Ltd
11.19.1 AXA Parenterals Ltd Corporation Information
11.19.2 AXA Parenterals Ltd Description, Business Overview and Total Revenue
11.19.3 AXA Parenterals Ltd Sales, Revenue and Gross Margin (2015-2020)
11.19.4 AXA Parenterals Ltd Products Offered
11.19.5 AXA Parenterals Ltd Recent Development
11.20 Acebright
11.20.1 Acebright Corporation Information
11.20.2 Acebright Description, Business Overview and Total Revenue
11.20.3 Acebright Sales, Revenue and Gross Margin (2015-2020)
11.20.4 Acebright Products Offered
11.20.5 Acebright Recent Development
11.21 Southwest Pharmaceutical
11.21.1 Southwest Pharmaceutical Corporation Information
11.21.2 Southwest Pharmaceutical Description, Business Overview and Total Revenue
11.21.3 Southwest Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.21.4 Southwest Pharmaceutical Products Offered
11.21.5 Southwest Pharmaceutical Recent Development
11.22 Abbott
11.22.1 Abbott Corporation Information
11.22.2 Abbott Description, Business Overview and Total Revenue
11.22.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.22.4 Abbott Products Offered
11.22.5 Abbott Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Parenteral Drugs Market Estimates and Projections by Region
12.1.1 Global Parenteral Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Parenteral Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Parenteral Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Parenteral Drugs Sales Forecast (2021-2026)
12.2.2 North America: Parenteral Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Parenteral Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Parenteral Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Parenteral Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Parenteral Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Parenteral Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Parenteral Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Parenteral Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Parenteral Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Parenteral Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Parenteral Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Parenteral Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Parenteral Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Parenteral Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Parenteral Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Parenteral Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Parenteral Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Parenteral Drugs Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Parenteral Drugs Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Parenteral Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Parenteral Drugs Product Introduction
1.2 Market Segments
1.3 Key Parenteral Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Parenteral Drugs Market Size Growth Rate by Type
1.4.2 LVP Drug
1.4.3 SVP Drug
1.5 Market by Application
1.5.1 Global Parenteral Drugs Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Medical Centers
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Parenteral Drugs Industry Impact
1.6.1 How the Covid-19 is Affecting the Parenteral Drugs Industry
1.6.1.1 Parenteral Drugs Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Parenteral Drugs Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Parenteral Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Parenteral Drugs Market Size Estimates and Forecasts
2.1.1 Global Parenteral Drugs Revenue 2015-2026
2.1.2 Global Parenteral Drugs Sales 2015-2026
2.2 Parenteral Drugs Market Size by Region: 2020 Versus 2026
2.2.1 Global Parenteral Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Parenteral Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL PARENTERAL DRUGS COMPETITOR LANDSCAPE BY PLAYERS
3.1 Parenteral Drugs Sales by Manufacturers
3.1.1 Parenteral Drugs Sales by Manufacturers (2015-2020)
3.1.2 Parenteral Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Parenteral Drugs Revenue by Manufacturers
3.2.1 Parenteral Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Parenteral Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Parenteral Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Parenteral Drugs Revenue in 2019
3.2.5 Global Parenteral Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Parenteral Drugs Price by Manufacturers
3.4 Parenteral Drugs Manufacturing Base Distribution, Product Types
3.4.1 Parenteral Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Parenteral Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Parenteral Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Parenteral Drugs Market Size by Type (2015-2020)
4.1.1 Global Parenteral Drugs Sales by Type (2015-2020)
4.1.2 Global Parenteral Drugs Revenue by Type (2015-2020)
4.1.3 Parenteral Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Parenteral Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Parenteral Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Parenteral Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Parenteral Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Parenteral Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Parenteral Drugs Market Size by Application (2015-2020)
5.1.1 Global Parenteral Drugs Sales by Application (2015-2020)
5.1.2 Global Parenteral Drugs Revenue by Application (2015-2020)
5.1.3 Parenteral Drugs Price by Application (2015-2020)
5.2 Parenteral Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Parenteral Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Parenteral Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Parenteral Drugs Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Parenteral Drugs by Country
6.1.1 North America Parenteral Drugs Sales by Country
6.1.2 North America Parenteral Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Parenteral Drugs Market Facts & Figures by Type
6.3 North America Parenteral Drugs Market Facts & Figures by Application
7 EUROPE
7.1 Europe Parenteral Drugs by Country
7.1.1 Europe Parenteral Drugs Sales by Country
7.1.2 Europe Parenteral Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Parenteral Drugs Market Facts & Figures by Type
7.3 Europe Parenteral Drugs Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Parenteral Drugs by Region
8.1.1 Asia Pacific Parenteral Drugs Sales by Region
8.1.2 Asia Pacific Parenteral Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Parenteral Drugs Market Facts & Figures by Type
8.3 Asia Pacific Parenteral Drugs Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Parenteral Drugs by Country
9.1.1 Latin America Parenteral Drugs Sales by Country
9.1.2 Latin America Parenteral Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Parenteral Drugs Market Facts & Figures by Type
9.3 Central & South America Parenteral Drugs Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Parenteral Drugs by Country
10.1.1 Middle East and Africa Parenteral Drugs Sales by Country
10.1.2 Middle East and Africa Parenteral Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Parenteral Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Parenteral Drugs Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Ostuka Pharmaceutical
11.1.1 Ostuka Pharmaceutical Corporation Information
11.1.2 Ostuka Pharmaceutical Description, Business Overview and Total Revenue
11.1.3 Ostuka Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Ostuka Pharmaceutical Parenteral Drugs Products Offered
11.1.5 Ostuka Pharmaceutical Recent Development
11.2 Teva Pharmaceutical Industries
11.2.1 Teva Pharmaceutical Industries Corporation Information
11.2.2 Teva Pharmaceutical Industries Description, Business Overview and Total Revenue
11.2.3 Teva Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Teva Pharmaceutical Industries Parenteral Drugs Products Offered
11.2.5 Teva Pharmaceutical Industries Recent Development
11.3 Kelun Pharma
11.3.1 Kelun Pharma Corporation Information
11.3.2 Kelun Pharma Description, Business Overview and Total Revenue
11.3.3 Kelun Pharma Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Kelun Pharma Parenteral Drugs Products Offered
11.3.5 Kelun Pharma Recent Development
11.4 Cook Pharmica
11.4.1 Cook Pharmica Corporation Information
11.4.2 Cook Pharmica Description, Business Overview and Total Revenue
11.4.3 Cook Pharmica Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Cook Pharmica Parenteral Drugs Products Offered
11.4.5 Cook Pharmica Recent Development
11.5 Patheon
11.5.1 Patheon Corporation Information
11.5.2 Patheon Description, Business Overview and Total Revenue
11.5.3 Patheon Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Patheon Parenteral Drugs Products Offered
11.5.5 Patheon Recent Development
11.6 BAG Healthcare
11.6.1 BAG Healthcare Corporation Information
11.6.2 BAG Healthcare Description, Business Overview and Total Revenue
11.6.3 BAG Healthcare Sales, Revenue and Gross Margin (2015-2020)
11.6.4 BAG Healthcare Parenteral Drugs Products Offered
11.6.5 BAG Healthcare Recent Development
11.7 Beximco Pharma
11.7.1 Beximco Pharma Corporation Information
11.7.2 Beximco Pharma Description, Business Overview and Total Revenue
11.7.3 Beximco Pharma Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Beximco Pharma Parenteral Drugs Products Offered
11.7.5 Beximco Pharma Recent Development
11.8 Baxter Healthcare Corporation
11.8.1 Baxter Healthcare Corporation Corporation Information
11.8.2 Baxter Healthcare Corporation Description, Business Overview and Total Revenue
11.8.3 Baxter Healthcare Corporation Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Baxter Healthcare Corporation Parenteral Drugs Products Offered
11.8.5 Baxter Healthcare Corporation Recent Development
11.9 B. Braun
11.9.1 B. Braun Corporation Information
11.9.2 B. Braun Description, Business Overview and Total Revenue
11.9.3 B. Braun Sales, Revenue and Gross Margin (2015-2020)
11.9.4 B. Braun Parenteral Drugs Products Offered
11.9.5 B. Braun Recent Development
11.10 Fresenius
11.10.1 Fresenius Corporation Information
11.10.2 Fresenius Description, Business Overview and Total Revenue
11.10.3 Fresenius Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Fresenius Parenteral Drugs Products Offered
11.10.5 Fresenius Recent Development
11.1 Ostuka Pharmaceutical
11.1.1 Ostuka Pharmaceutical Corporation Information
11.1.2 Ostuka Pharmaceutical Description, Business Overview and Total Revenue
11.1.3 Ostuka Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Ostuka Pharmaceutical Parenteral Drugs Products Offered
11.1.5 Ostuka Pharmaceutical Recent Development
11.12 BML Parenteral Drugs
11.12.1 BML Parenteral Drugs Corporation Information
11.12.2 BML Parenteral Drugs Description, Business Overview and Total Revenue
11.12.3 BML Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
11.12.4 BML Parenteral Drugs Products Offered
11.12.5 BML Parenteral Drugs Recent Development
11.13 Pfizer (Hospira)
11.13.1 Pfizer (Hospira) Corporation Information
11.13.2 Pfizer (Hospira) Description, Business Overview and Total Revenue
11.13.3 Pfizer (Hospira) Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Pfizer (Hospira) Products Offered
11.13.5 Pfizer (Hospira) Recent Development
11.14 Pisa
11.14.1 Pisa Corporation Information
11.14.2 Pisa Description, Business Overview and Total Revenue
11.14.3 Pisa Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Pisa Products Offered
11.14.5 Pisa Recent Development
11.15 Ozon Pharmaceuticals Ltd
11.15.1 Ozon Pharmaceuticals Ltd Corporation Information
11.15.2 Ozon Pharmaceuticals Ltd Description, Business Overview and Total Revenue
11.15.3 Ozon Pharmaceuticals Ltd Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Ozon Pharmaceuticals Ltd Products Offered
11.15.5 Ozon Pharmaceuticals Ltd Recent Development
11.16 Aspen Holdings
11.16.1 Aspen Holdings Corporation Information
11.16.2 Aspen Holdings Description, Business Overview and Total Revenue
11.16.3 Aspen Holdings Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Aspen Holdings Products Offered
11.16.5 Aspen Holdings Recent Development
11.17 PSI Ltd
11.17.1 PSI Ltd Corporation Information
11.17.2 PSI Ltd Description, Business Overview and Total Revenue
11.17.3 PSI Ltd Sales, Revenue and Gross Margin (2015-2020)
11.17.4 PSI Ltd Products Offered
11.17.5 PSI Ltd Recent Development
11.18 Wintac Limited
11.18.1 Wintac Limited Corporation Information
11.18.2 Wintac Limited Description, Business Overview and Total Revenue
11.18.3 Wintac Limited Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Wintac Limited Products Offered
11.18.5 Wintac Limited Recent Development
11.19 AXA Parenterals Ltd
11.19.1 AXA Parenterals Ltd Corporation Information
11.19.2 AXA Parenterals Ltd Description, Business Overview and Total Revenue
11.19.3 AXA Parenterals Ltd Sales, Revenue and Gross Margin (2015-2020)
11.19.4 AXA Parenterals Ltd Products Offered
11.19.5 AXA Parenterals Ltd Recent Development
11.20 Acebright
11.20.1 Acebright Corporation Information
11.20.2 Acebright Description, Business Overview and Total Revenue
11.20.3 Acebright Sales, Revenue and Gross Margin (2015-2020)
11.20.4 Acebright Products Offered
11.20.5 Acebright Recent Development
11.21 Southwest Pharmaceutical
11.21.1 Southwest Pharmaceutical Corporation Information
11.21.2 Southwest Pharmaceutical Description, Business Overview and Total Revenue
11.21.3 Southwest Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.21.4 Southwest Pharmaceutical Products Offered
11.21.5 Southwest Pharmaceutical Recent Development
11.22 Abbott
11.22.1 Abbott Corporation Information
11.22.2 Abbott Description, Business Overview and Total Revenue
11.22.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.22.4 Abbott Products Offered
11.22.5 Abbott Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Parenteral Drugs Market Estimates and Projections by Region
12.1.1 Global Parenteral Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Parenteral Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Parenteral Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Parenteral Drugs Sales Forecast (2021-2026)
12.2.2 North America: Parenteral Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Parenteral Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Parenteral Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Parenteral Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Parenteral Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Parenteral Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Parenteral Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Parenteral Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Parenteral Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Parenteral Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Parenteral Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Parenteral Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Parenteral Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Parenteral Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Parenteral Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Parenteral Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Parenteral Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Parenteral Drugs Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Parenteral Drugs Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Parenteral Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Parenteral Drugs Market Segments
Table 2. Ranking of Global Top Parenteral Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Parenteral Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of LVP Drug
Table 5. Major Manufacturers of SVP Drug
Table 6. COVID-19 Impact Global Market: (Four Parenteral Drugs Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Parenteral Drugs Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Parenteral Drugs Players to Combat Covid-19 Impact
Table 11. Global Parenteral Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 12. Global Parenteral Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 13. Global Parenteral Drugs Sales by Regions 2015-2020 (K Units)
Table 14. Global Parenteral Drugs Sales Market Share by Regions (2015-2020)
Table 15. Global Parenteral Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Parenteral Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 17. Global Parenteral Drugs Sales Share by Manufacturers (2015-2020)
Table 18. Global Parenteral Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Parenteral Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parenteral Drugs as of 2019)
Table 20. Parenteral Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Parenteral Drugs Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Parenteral Drugs Price (2015-2020) (USD/Unit)
Table 23. Parenteral Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Parenteral Drugs Product Type
Table 25. Date of International Manufacturers Enter into Parenteral Drugs Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Parenteral Drugs Sales by Type (2015-2020) (K Units)
Table 28. Global Parenteral Drugs Sales Share by Type (2015-2020)
Table 29. Global Parenteral Drugs Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Parenteral Drugs Revenue Share by Type (2015-2020)
Table 31. Parenteral Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 32. Global Parenteral Drugs Sales by Application (2015-2020) (K Units)
Table 33. Global Parenteral Drugs Sales Share by Application (2015-2020)
Table 34. North America Parenteral Drugs Sales by Country (2015-2020) (K Units)
Table 35. North America Parenteral Drugs Sales Market Share by Country (2015-2020)
Table 36. North America Parenteral Drugs Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Parenteral Drugs Revenue Market Share by Country (2015-2020)
Table 38. North America Parenteral Drugs Sales by Type (2015-2020) (K Units)
Table 39. North America Parenteral Drugs Sales Market Share by Type (2015-2020)
Table 40. North America Parenteral Drugs Sales by Application (2015-2020) (K Units)
Table 41. North America Parenteral Drugs Sales Market Share by Application (2015-2020)
Table 42. Europe Parenteral Drugs Sales by Country (2015-2020) (K Units)
Table 43. Europe Parenteral Drugs Sales Market Share by Country (2015-2020)
Table 44. Europe Parenteral Drugs Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Parenteral Drugs Revenue Market Share by Country (2015-2020)
Table 46. Europe Parenteral Drugs Sales by Type (2015-2020) (K Units)
Table 47. Europe Parenteral Drugs Sales Market Share by Type (2015-2020)
Table 48. Europe Parenteral Drugs Sales by Application (2015-2020) (K Units)
Table 49. Europe Parenteral Drugs Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Parenteral Drugs Sales by Region (2015-2020) (K Units)
Table 51. Asia Pacific Parenteral Drugs Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Parenteral Drugs Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Parenteral Drugs Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Parenteral Drugs Sales by Type (2015-2020) (K Units)
Table 55. Asia Pacific Parenteral Drugs Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Parenteral Drugs Sales by Application (2015-2020) (K Units)
Table 57. Asia Pacific Parenteral Drugs Sales Market Share by Application (2015-2020)
Table 58. Latin America Parenteral Drugs Sales by Country (2015-2020) (K Units)
Table 59. Latin America Parenteral Drugs Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Parenteral Drugs Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Parenteral Drugs Revenue Market Share by Country (2015-2020)
Table 62. Latin America Parenteral Drugs Sales by Type (2015-2020) (K Units)
Table 63. Latin America Parenteral Drugs Sales Market Share by Type (2015-2020)
Table 64. Latin America Parenteral Drugs Sales by Application (2015-2020) (K Units)
Table 65. Latin America Parenteral Drugs Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Parenteral Drugs Sales by Country (2015-2020) (K Units)
Table 67. Middle East and Africa Parenteral Drugs Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Parenteral Drugs Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Parenteral Drugs Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Parenteral Drugs Sales by Type (2015-2020) (K Units)
Table 71. Middle East and Africa Parenteral Drugs Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Parenteral Drugs Sales by Application (2015-2020) (K Units)
Table 73. Middle East and Africa Parenteral Drugs Sales Market Share by Application (2015-2020)
Table 74. Ostuka Pharmaceutical Corporation Information
Table 75. Ostuka Pharmaceutical Description and Major Businesses
Table 76. Ostuka Pharmaceutical Parenteral Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Ostuka Pharmaceutical Product
Table 78. Ostuka Pharmaceutical Recent Development
Table 79. Teva Pharmaceutical Industries Corporation Information
Table 80. Teva Pharmaceutical Industries Description and Major Businesses
Table 81. Teva Pharmaceutical Industries Parenteral Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Teva Pharmaceutical Industries Product
Table 83. Teva Pharmaceutical Industries Recent Development
Table 84. Kelun Pharma Corporation Information
Table 85. Kelun Pharma Description and Major Businesses
Table 86. Kelun Pharma Parenteral Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Kelun Pharma Product
Table 88. Kelun Pharma Recent Development
Table 89. Cook Pharmica Corporation Information
Table 90. Cook Pharmica Description and Major Businesses
Table 91. Cook Pharmica Parenteral Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Cook Pharmica Product
Table 93. Cook Pharmica Recent Development
Table 94. Patheon Corporation Information
Table 95. Patheon Description and Major Businesses
Table 96. Patheon Parenteral Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Patheon Product
Table 98. Patheon Recent Development
Table 99. BAG Healthcare Corporation Information
Table 100. BAG Healthcare Description and Major Businesses
Table 101. BAG Healthcare Parenteral Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. BAG Healthcare Product
Table 103. BAG Healthcare Recent Development
Table 104. Beximco Pharma Corporation Information
Table 105. Beximco Pharma Description and Major Businesses
Table 106. Beximco Pharma Parenteral Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Beximco Pharma Product
Table 108. Beximco Pharma Recent Development
Table 109. Baxter Healthcare Corporation Corporation Information
Table 110. Baxter Healthcare Corporation Description and Major Businesses
Table 111. Baxter Healthcare Corporation Parenteral Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Baxter Healthcare Corporation Product
Table 113. Baxter Healthcare Corporation Recent Development
Table 114. B. Braun Corporation Information
Table 115. B. Braun Description and Major Businesses
Table 116. B. Braun Parenteral Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. B. Braun Product
Table 118. B. Braun Recent Development
Table 119. Fresenius Corporation Information
Table 120. Fresenius Description and Major Businesses
Table 121. Fresenius Parenteral Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Fresenius Product
Table 123. Fresenius Recent Development
Table 124. Albert David Corporation Information
Table 125. Albert David Description and Major Businesses
Table 126. Albert David Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 127. Albert David Product
Table 128. Albert David Recent Development
Table 129. BML Parenteral Drugs Corporation Information
Table 130. BML Parenteral Drugs Description and Major Businesses
Table 131. BML Parenteral Drugs Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 132. BML Parenteral Drugs Product
Table 133. BML Parenteral Drugs Recent Development
Table 134. Pfizer (Hospira) Corporation Information
Table 135. Pfizer (Hospira) Description and Major Businesses
Table 136. Pfizer (Hospira) Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 137. Pfizer (Hospira) Product
Table 138. Pfizer (Hospira) Recent Development
Table 139. Pisa Corporation Information
Table 140. Pisa Description and Major Businesses
Table 141. Pisa Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 142. Pisa Product
Table 143. Pisa Recent Development
Table 144. Ozon Pharmaceuticals Ltd Corporation Information
Table 145. Ozon Pharmaceuticals Ltd Description and Major Businesses
Table 146. Ozon Pharmaceuticals Ltd Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 147. Ozon Pharmaceuticals Ltd Product
Table 148. Ozon Pharmaceuticals Ltd Recent Development
Table 149. Aspen Holdings Corporation Information
Table 150. Aspen Holdings Description and Major Businesses
Table 151. Aspen Holdings Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 152. Aspen Holdings Product
Table 153. Aspen Holdings Recent Development
Table 154. PSI Ltd Corporation Information
Table 155. PSI Ltd Description and Major Businesses
Table 156. PSI Ltd Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 157. PSI Ltd Product
Table 158. PSI Ltd Recent Development
Table 159. Wintac Limited Corporation Information
Table 160. Wintac Limited Description and Major Businesses
Table 161. Wintac Limited Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 162. Wintac Limited Product
Table 163. Wintac Limited Recent Development
Table 164. AXA Parenterals Ltd Corporation Information
Table 165. AXA Parenterals Ltd Description and Major Businesses
Table 166. AXA Parenterals Ltd Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 167. AXA Parenterals Ltd Product
Table 168. AXA Parenterals Ltd Recent Development
Table 169. Acebright Corporation Information
Table 170. Acebright Description and Major Businesses
Table 171. Acebright Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 172. Acebright Product
Table 173. Acebright Recent Development
Table 174. Southwest Pharmaceutical Corporation Information
Table 175. Southwest Pharmaceutical Description and Major Businesses
Table 176. Southwest Pharmaceutical Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 177. Southwest Pharmaceutical Product
Table 178. Southwest Pharmaceutical Recent Development
Table 179. Abbott Corporation Information
Table 180. Abbott Description and Major Businesses
Table 181. Abbott Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 182. Abbott Product
Table 183. Abbott Recent Development
Table 184. Global Parenteral Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 185. Global Parenteral Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 186. Global Parenteral Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 187. Global Parenteral Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 188. North America: Parenteral Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 189. North America: Parenteral Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 190. Europe: Parenteral Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 191. Europe: Parenteral Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 192. Asia Pacific: Parenteral Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 193. Asia Pacific: Parenteral Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 194. Latin America: Parenteral Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 195. Latin America: Parenteral Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 196. Middle East and Africa: Parenteral Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 197. Middle East and Africa: Parenteral Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 198. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 199. Key Challenges
Table 200. Market Risks
Table 201. Main Points Interviewed from Key Parenteral Drugs Players
Table 202. Parenteral Drugs Customers List
Table 203. Parenteral Drugs Distributors List
Table 204. Research Programs/Design for This Report
Table 205. Key Data Information from Secondary Sources
Table 206. Key Data Information from Primary Sources
Table 1. Parenteral Drugs Market Segments
Table 2. Ranking of Global Top Parenteral Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Parenteral Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of LVP Drug
Table 5. Major Manufacturers of SVP Drug
Table 6. COVID-19 Impact Global Market: (Four Parenteral Drugs Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Parenteral Drugs Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Parenteral Drugs Players to Combat Covid-19 Impact
Table 11. Global Parenteral Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 12. Global Parenteral Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 13. Global Parenteral Drugs Sales by Regions 2015-2020 (K Units)
Table 14. Global Parenteral Drugs Sales Market Share by Regions (2015-2020)
Table 15. Global Parenteral Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Parenteral Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 17. Global Parenteral Drugs Sales Share by Manufacturers (2015-2020)
Table 18. Global Parenteral Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Parenteral Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parenteral Drugs as of 2019)
Table 20. Parenteral Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Parenteral Drugs Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Parenteral Drugs Price (2015-2020) (USD/Unit)
Table 23. Parenteral Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Parenteral Drugs Product Type
Table 25. Date of International Manufacturers Enter into Parenteral Drugs Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Parenteral Drugs Sales by Type (2015-2020) (K Units)
Table 28. Global Parenteral Drugs Sales Share by Type (2015-2020)
Table 29. Global Parenteral Drugs Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Parenteral Drugs Revenue Share by Type (2015-2020)
Table 31. Parenteral Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 32. Global Parenteral Drugs Sales by Application (2015-2020) (K Units)
Table 33. Global Parenteral Drugs Sales Share by Application (2015-2020)
Table 34. North America Parenteral Drugs Sales by Country (2015-2020) (K Units)
Table 35. North America Parenteral Drugs Sales Market Share by Country (2015-2020)
Table 36. North America Parenteral Drugs Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Parenteral Drugs Revenue Market Share by Country (2015-2020)
Table 38. North America Parenteral Drugs Sales by Type (2015-2020) (K Units)
Table 39. North America Parenteral Drugs Sales Market Share by Type (2015-2020)
Table 40. North America Parenteral Drugs Sales by Application (2015-2020) (K Units)
Table 41. North America Parenteral Drugs Sales Market Share by Application (2015-2020)
Table 42. Europe Parenteral Drugs Sales by Country (2015-2020) (K Units)
Table 43. Europe Parenteral Drugs Sales Market Share by Country (2015-2020)
Table 44. Europe Parenteral Drugs Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Parenteral Drugs Revenue Market Share by Country (2015-2020)
Table 46. Europe Parenteral Drugs Sales by Type (2015-2020) (K Units)
Table 47. Europe Parenteral Drugs Sales Market Share by Type (2015-2020)
Table 48. Europe Parenteral Drugs Sales by Application (2015-2020) (K Units)
Table 49. Europe Parenteral Drugs Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Parenteral Drugs Sales by Region (2015-2020) (K Units)
Table 51. Asia Pacific Parenteral Drugs Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Parenteral Drugs Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Parenteral Drugs Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Parenteral Drugs Sales by Type (2015-2020) (K Units)
Table 55. Asia Pacific Parenteral Drugs Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Parenteral Drugs Sales by Application (2015-2020) (K Units)
Table 57. Asia Pacific Parenteral Drugs Sales Market Share by Application (2015-2020)
Table 58. Latin America Parenteral Drugs Sales by Country (2015-2020) (K Units)
Table 59. Latin America Parenteral Drugs Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Parenteral Drugs Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Parenteral Drugs Revenue Market Share by Country (2015-2020)
Table 62. Latin America Parenteral Drugs Sales by Type (2015-2020) (K Units)
Table 63. Latin America Parenteral Drugs Sales Market Share by Type (2015-2020)
Table 64. Latin America Parenteral Drugs Sales by Application (2015-2020) (K Units)
Table 65. Latin America Parenteral Drugs Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Parenteral Drugs Sales by Country (2015-2020) (K Units)
Table 67. Middle East and Africa Parenteral Drugs Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Parenteral Drugs Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Parenteral Drugs Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Parenteral Drugs Sales by Type (2015-2020) (K Units)
Table 71. Middle East and Africa Parenteral Drugs Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Parenteral Drugs Sales by Application (2015-2020) (K Units)
Table 73. Middle East and Africa Parenteral Drugs Sales Market Share by Application (2015-2020)
Table 74. Ostuka Pharmaceutical Corporation Information
Table 75. Ostuka Pharmaceutical Description and Major Businesses
Table 76. Ostuka Pharmaceutical Parenteral Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Ostuka Pharmaceutical Product
Table 78. Ostuka Pharmaceutical Recent Development
Table 79. Teva Pharmaceutical Industries Corporation Information
Table 80. Teva Pharmaceutical Industries Description and Major Businesses
Table 81. Teva Pharmaceutical Industries Parenteral Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Teva Pharmaceutical Industries Product
Table 83. Teva Pharmaceutical Industries Recent Development
Table 84. Kelun Pharma Corporation Information
Table 85. Kelun Pharma Description and Major Businesses
Table 86. Kelun Pharma Parenteral Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Kelun Pharma Product
Table 88. Kelun Pharma Recent Development
Table 89. Cook Pharmica Corporation Information
Table 90. Cook Pharmica Description and Major Businesses
Table 91. Cook Pharmica Parenteral Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Cook Pharmica Product
Table 93. Cook Pharmica Recent Development
Table 94. Patheon Corporation Information
Table 95. Patheon Description and Major Businesses
Table 96. Patheon Parenteral Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Patheon Product
Table 98. Patheon Recent Development
Table 99. BAG Healthcare Corporation Information
Table 100. BAG Healthcare Description and Major Businesses
Table 101. BAG Healthcare Parenteral Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. BAG Healthcare Product
Table 103. BAG Healthcare Recent Development
Table 104. Beximco Pharma Corporation Information
Table 105. Beximco Pharma Description and Major Businesses
Table 106. Beximco Pharma Parenteral Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Beximco Pharma Product
Table 108. Beximco Pharma Recent Development
Table 109. Baxter Healthcare Corporation Corporation Information
Table 110. Baxter Healthcare Corporation Description and Major Businesses
Table 111. Baxter Healthcare Corporation Parenteral Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Baxter Healthcare Corporation Product
Table 113. Baxter Healthcare Corporation Recent Development
Table 114. B. Braun Corporation Information
Table 115. B. Braun Description and Major Businesses
Table 116. B. Braun Parenteral Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. B. Braun Product
Table 118. B. Braun Recent Development
Table 119. Fresenius Corporation Information
Table 120. Fresenius Description and Major Businesses
Table 121. Fresenius Parenteral Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Fresenius Product
Table 123. Fresenius Recent Development
Table 124. Albert David Corporation Information
Table 125. Albert David Description and Major Businesses
Table 126. Albert David Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 127. Albert David Product
Table 128. Albert David Recent Development
Table 129. BML Parenteral Drugs Corporation Information
Table 130. BML Parenteral Drugs Description and Major Businesses
Table 131. BML Parenteral Drugs Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 132. BML Parenteral Drugs Product
Table 133. BML Parenteral Drugs Recent Development
Table 134. Pfizer (Hospira) Corporation Information
Table 135. Pfizer (Hospira) Description and Major Businesses
Table 136. Pfizer (Hospira) Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 137. Pfizer (Hospira) Product
Table 138. Pfizer (Hospira) Recent Development
Table 139. Pisa Corporation Information
Table 140. Pisa Description and Major Businesses
Table 141. Pisa Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 142. Pisa Product
Table 143. Pisa Recent Development
Table 144. Ozon Pharmaceuticals Ltd Corporation Information
Table 145. Ozon Pharmaceuticals Ltd Description and Major Businesses
Table 146. Ozon Pharmaceuticals Ltd Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 147. Ozon Pharmaceuticals Ltd Product
Table 148. Ozon Pharmaceuticals Ltd Recent Development
Table 149. Aspen Holdings Corporation Information
Table 150. Aspen Holdings Description and Major Businesses
Table 151. Aspen Holdings Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 152. Aspen Holdings Product
Table 153. Aspen Holdings Recent Development
Table 154. PSI Ltd Corporation Information
Table 155. PSI Ltd Description and Major Businesses
Table 156. PSI Ltd Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 157. PSI Ltd Product
Table 158. PSI Ltd Recent Development
Table 159. Wintac Limited Corporation Information
Table 160. Wintac Limited Description and Major Businesses
Table 161. Wintac Limited Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 162. Wintac Limited Product
Table 163. Wintac Limited Recent Development
Table 164. AXA Parenterals Ltd Corporation Information
Table 165. AXA Parenterals Ltd Description and Major Businesses
Table 166. AXA Parenterals Ltd Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 167. AXA Parenterals Ltd Product
Table 168. AXA Parenterals Ltd Recent Development
Table 169. Acebright Corporation Information
Table 170. Acebright Description and Major Businesses
Table 171. Acebright Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 172. Acebright Product
Table 173. Acebright Recent Development
Table 174. Southwest Pharmaceutical Corporation Information
Table 175. Southwest Pharmaceutical Description and Major Businesses
Table 176. Southwest Pharmaceutical Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 177. Southwest Pharmaceutical Product
Table 178. Southwest Pharmaceutical Recent Development
Table 179. Abbott Corporation Information
Table 180. Abbott Description and Major Businesses
Table 181. Abbott Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 182. Abbott Product
Table 183. Abbott Recent Development
Table 184. Global Parenteral Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 185. Global Parenteral Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 186. Global Parenteral Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 187. Global Parenteral Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 188. North America: Parenteral Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 189. North America: Parenteral Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 190. Europe: Parenteral Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 191. Europe: Parenteral Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 192. Asia Pacific: Parenteral Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 193. Asia Pacific: Parenteral Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 194. Latin America: Parenteral Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 195. Latin America: Parenteral Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 196. Middle East and Africa: Parenteral Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 197. Middle East and Africa: Parenteral Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 198. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 199. Key Challenges
Table 200. Market Risks
Table 201. Main Points Interviewed from Key Parenteral Drugs Players
Table 202. Parenteral Drugs Customers List
Table 203. Parenteral Drugs Distributors List
Table 204. Research Programs/Design for This Report
Table 205. Key Data Information from Secondary Sources
Table 206. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Parenteral Drugs Product Picture
Figure 2. Global Parenteral Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. LVP Drug Product Picture
Figure 4. SVP Drug Product Picture
Figure 5. Global Parenteral Drugs Sales Market Share by Application in 2020 & 2026
Figure 6. Hospitals
Figure 7. Medical Centers
Figure 8. Others
Figure 9. Parenteral Drugs Report Years Considered
Figure 10. Global Parenteral Drugs Market Size 2015-2026 (US$ Million)
Figure 11. Global Parenteral Drugs Sales 2015-2026 (K Units)
Figure 12. Global Parenteral Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Parenteral Drugs Sales Market Share by Region (2015-2020)
Figure 14. Global Parenteral Drugs Sales Market Share by Region in 2019
Figure 15. Global Parenteral Drugs Revenue Market Share by Region (2015-2020)
Figure 16. Global Parenteral Drugs Revenue Market Share by Region in 2019
Figure 17. Global Parenteral Drugs Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Parenteral Drugs Revenue in 2019
Figure 19. Parenteral Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Parenteral Drugs Sales Market Share by Type (2015-2020)
Figure 21. Global Parenteral Drugs Sales Market Share by Type in 2019
Figure 22. Global Parenteral Drugs Revenue Market Share by Type (2015-2020)
Figure 23. Global Parenteral Drugs Revenue Market Share by Type in 2019
Figure 24. Global Parenteral Drugs Market Share by Price Range (2015-2020)
Figure 25. Global Parenteral Drugs Sales Market Share by Application (2015-2020)
Figure 26. Global Parenteral Drugs Sales Market Share by Application in 2019
Figure 27. Global Parenteral Drugs Revenue Market Share by Application (2015-2020)
Figure 28. Global Parenteral Drugs Revenue Market Share by Application in 2019
Figure 29. North America Parenteral Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 30. North America Parenteral Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Parenteral Drugs Sales Market Share by Country in 2019
Figure 32. North America Parenteral Drugs Revenue Market Share by Country in 2019
Figure 33. U.S. Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.S. Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 36. Canada Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Parenteral Drugs Market Share by Type in 2019
Figure 38. North America Parenteral Drugs Market Share by Application in 2019
Figure 39. Europe Parenteral Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 40. Europe Parenteral Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Parenteral Drugs Sales Market Share by Country in 2019
Figure 42. Europe Parenteral Drugs Revenue Market Share by Country in 2019
Figure 43. Germany Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 44. Germany Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 46. France Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 48. U.K. Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 50. Italy Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 52. Russia Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Parenteral Drugs Market Share by Type in 2019
Figure 54. Europe Parenteral Drugs Market Share by Application in 2019
Figure 55. Asia Pacific Parenteral Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 56. Asia Pacific Parenteral Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Parenteral Drugs Sales Market Share by Region in 2019
Figure 58. Asia Pacific Parenteral Drugs Revenue Market Share by Region in 2019
Figure 59. China Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 60. China Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 62. Japan Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 64. South Korea Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 66. India Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 68. Australia Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 70. Taiwan Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 72. Indonesia Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 74. Thailand Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 76. Malaysia Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 78. Philippines Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 80. Vietnam Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Parenteral Drugs Market Share by Type in 2019
Figure 82. Asia Pacific Parenteral Drugs Market Share by Application in 2019
Figure 83. Latin America Parenteral Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 84. Latin America Parenteral Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Parenteral Drugs Sales Market Share by Country in 2019
Figure 86. Latin America Parenteral Drugs Revenue Market Share by Country in 2019
Figure 87. Mexico Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 88. Mexico Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 90. Brazil Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 92. Argentina Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Parenteral Drugs Market Share by Type in 2019
Figure 94. Latin America Parenteral Drugs Market Share by Application in 2019
Figure 95. Middle East and Africa Parenteral Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 96. Middle East and Africa Parenteral Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Parenteral Drugs Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Parenteral Drugs Revenue Market Share by Country in 2019
Figure 99. Turkey Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 100. Turkey Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 102. Saudi Arabia Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 104. U.A.E Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Parenteral Drugs Market Share by Type in 2019
Figure 106. Middle East and Africa Parenteral Drugs Market Share by Application in 2019
Figure 107. Ostuka Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Teva Pharmaceutical Industries Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Kelun Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Cook Pharmica Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Patheon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. BAG Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Beximco Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Baxter Healthcare Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. B. Braun Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Fresenius Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Albert David Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. BML Parenteral Drugs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Pfizer (Hospira) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Pisa Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. Ozon Pharmaceuticals Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 122. Aspen Holdings Total Revenue (US$ Million): 2019 Compared with 2018
Figure 123. PSI Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 124. Wintac Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 125. AXA Parenterals Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 126. Acebright Total Revenue (US$ Million): 2019 Compared with 2018
Figure 127. Southwest Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 128. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 129. North America Parenteral Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 130. North America Parenteral Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 131. Europe Parenteral Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 132. Europe Parenteral Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 133. Asia Pacific Parenteral Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 134. Asia Pacific Parenteral Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 135. Latin America Parenteral Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 136. Latin America Parenteral Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 137. Middle East and Africa Parenteral Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 138. Middle East and Africa Parenteral Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 139. Porter's Five Forces Analysis
Figure 140. Channels of Distribution
Figure 141. Distributors Profiles
Figure 142. Bottom-up and Top-down Approaches for This Report
Figure 143. Data Triangulation
Figure 144. Key Executives Interviewed
Figure 1. Parenteral Drugs Product Picture
Figure 2. Global Parenteral Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. LVP Drug Product Picture
Figure 4. SVP Drug Product Picture
Figure 5. Global Parenteral Drugs Sales Market Share by Application in 2020 & 2026
Figure 6. Hospitals
Figure 7. Medical Centers
Figure 8. Others
Figure 9. Parenteral Drugs Report Years Considered
Figure 10. Global Parenteral Drugs Market Size 2015-2026 (US$ Million)
Figure 11. Global Parenteral Drugs Sales 2015-2026 (K Units)
Figure 12. Global Parenteral Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Parenteral Drugs Sales Market Share by Region (2015-2020)
Figure 14. Global Parenteral Drugs Sales Market Share by Region in 2019
Figure 15. Global Parenteral Drugs Revenue Market Share by Region (2015-2020)
Figure 16. Global Parenteral Drugs Revenue Market Share by Region in 2019
Figure 17. Global Parenteral Drugs Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Parenteral Drugs Revenue in 2019
Figure 19. Parenteral Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Parenteral Drugs Sales Market Share by Type (2015-2020)
Figure 21. Global Parenteral Drugs Sales Market Share by Type in 2019
Figure 22. Global Parenteral Drugs Revenue Market Share by Type (2015-2020)
Figure 23. Global Parenteral Drugs Revenue Market Share by Type in 2019
Figure 24. Global Parenteral Drugs Market Share by Price Range (2015-2020)
Figure 25. Global Parenteral Drugs Sales Market Share by Application (2015-2020)
Figure 26. Global Parenteral Drugs Sales Market Share by Application in 2019
Figure 27. Global Parenteral Drugs Revenue Market Share by Application (2015-2020)
Figure 28. Global Parenteral Drugs Revenue Market Share by Application in 2019
Figure 29. North America Parenteral Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 30. North America Parenteral Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Parenteral Drugs Sales Market Share by Country in 2019
Figure 32. North America Parenteral Drugs Revenue Market Share by Country in 2019
Figure 33. U.S. Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.S. Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 36. Canada Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Parenteral Drugs Market Share by Type in 2019
Figure 38. North America Parenteral Drugs Market Share by Application in 2019
Figure 39. Europe Parenteral Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 40. Europe Parenteral Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Parenteral Drugs Sales Market Share by Country in 2019
Figure 42. Europe Parenteral Drugs Revenue Market Share by Country in 2019
Figure 43. Germany Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 44. Germany Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 46. France Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 48. U.K. Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 50. Italy Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 52. Russia Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Parenteral Drugs Market Share by Type in 2019
Figure 54. Europe Parenteral Drugs Market Share by Application in 2019
Figure 55. Asia Pacific Parenteral Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 56. Asia Pacific Parenteral Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Parenteral Drugs Sales Market Share by Region in 2019
Figure 58. Asia Pacific Parenteral Drugs Revenue Market Share by Region in 2019
Figure 59. China Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 60. China Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 62. Japan Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 64. South Korea Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 66. India Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 68. Australia Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 70. Taiwan Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 72. Indonesia Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 74. Thailand Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 76. Malaysia Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 78. Philippines Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 80. Vietnam Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Parenteral Drugs Market Share by Type in 2019
Figure 82. Asia Pacific Parenteral Drugs Market Share by Application in 2019
Figure 83. Latin America Parenteral Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 84. Latin America Parenteral Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Parenteral Drugs Sales Market Share by Country in 2019
Figure 86. Latin America Parenteral Drugs Revenue Market Share by Country in 2019
Figure 87. Mexico Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 88. Mexico Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 90. Brazil Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 92. Argentina Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Parenteral Drugs Market Share by Type in 2019
Figure 94. Latin America Parenteral Drugs Market Share by Application in 2019
Figure 95. Middle East and Africa Parenteral Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 96. Middle East and Africa Parenteral Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Parenteral Drugs Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Parenteral Drugs Revenue Market Share by Country in 2019
Figure 99. Turkey Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 100. Turkey Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 102. Saudi Arabia Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 104. U.A.E Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Parenteral Drugs Market Share by Type in 2019
Figure 106. Middle East and Africa Parenteral Drugs Market Share by Application in 2019
Figure 107. Ostuka Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Teva Pharmaceutical Industries Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Kelun Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Cook Pharmica Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Patheon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. BAG Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Beximco Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Baxter Healthcare Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. B. Braun Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Fresenius Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Albert David Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. BML Parenteral Drugs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Pfizer (Hospira) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Pisa Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. Ozon Pharmaceuticals Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 122. Aspen Holdings Total Revenue (US$ Million): 2019 Compared with 2018
Figure 123. PSI Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 124. Wintac Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 125. AXA Parenterals Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 126. Acebright Total Revenue (US$ Million): 2019 Compared with 2018
Figure 127. Southwest Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 128. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 129. North America Parenteral Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 130. North America Parenteral Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 131. Europe Parenteral Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 132. Europe Parenteral Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 133. Asia Pacific Parenteral Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 134. Asia Pacific Parenteral Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 135. Latin America Parenteral Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 136. Latin America Parenteral Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 137. Middle East and Africa Parenteral Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 138. Middle East and Africa Parenteral Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 139. Porter's Five Forces Analysis
Figure 140. Channels of Distribution
Figure 141. Distributors Profiles
Figure 142. Bottom-up and Top-down Approaches for This Report
Figure 143. Data Triangulation
Figure 144. Key Executives Interviewed
